BLUE BIRD CORP (BLBD) Stock Fundamental Analysis

NASDAQ:BLBD • US0953061068

55.96 USD
-1.81 (-3.13%)
At close: Feb 12, 2026
55.96 USD
0 (0%)
After Hours: 2/12/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Taking everything into account, BLBD scores 6 out of 10 in our fundamental rating. BLBD was compared to 131 industry peers in the Machinery industry. BLBD gets an excellent profitability rating and is at the same time showing great financial health properties. BLBD scores decently on growth, while it is valued quite cheap. This could make an interesting combination. This makes BLBD very considerable for value and quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year BLBD was profitable.
  • BLBD had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: BLBD reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: BLBD reported negative operating cash flow in multiple years.
BLBD Yearly Net Income VS EBIT VS OCF VS FCFBLBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

1.2 Ratios

  • BLBD has a Return On Assets of 20.20%. This is amongst the best in the industry. BLBD outperforms 98.47% of its industry peers.
  • BLBD has a better Return On Equity (47.81%) than 97.71% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 31.20%, BLBD belongs to the top of the industry, outperforming 99.24% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for BLBD is significantly above the industry average of 10.21%.
  • The last Return On Invested Capital (31.20%) for BLBD is above the 3 year average (29.27%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 20.2%
ROE 47.81%
ROIC 31.2%
ROA(3y)15.41%
ROA(5y)6.73%
ROE(3y)58.56%
ROE(5y)N/A
ROIC(3y)29.27%
ROIC(5y)N/A
BLBD Yearly ROA, ROE, ROICBLBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

  • BLBD has a Profit Margin of 8.65%. This is in the better half of the industry: BLBD outperforms 70.23% of its industry peers.
  • In the last couple of years the Profit Margin of BLBD has grown nicely.
  • The Operating Margin of BLBD (11.46%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of BLBD has grown nicely.
  • BLBD's Gross Margin of 20.97% is on the low side compared to the rest of the industry. BLBD is outperformed by 69.47% of its industry peers.
  • BLBD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.46%
PM (TTM) 8.65%
GM 20.97%
OM growth 3YN/A
OM growth 5Y35.18%
PM growth 3YN/A
PM growth 5Y44.13%
GM growth 3Y65.07%
GM growth 5Y13.39%
BLBD Yearly Profit, Operating, Gross MarginsBLBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BLBD is creating value.
  • The number of shares outstanding for BLBD has been reduced compared to 1 year ago.
  • The number of shares outstanding for BLBD has been increased compared to 5 years ago.
  • Compared to 1 year ago, BLBD has an improved debt to assets ratio.
BLBD Yearly Shares OutstandingBLBD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
BLBD Yearly Total Debt VS Total AssetsBLBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • BLBD has an Altman-Z score of 6.66. This indicates that BLBD is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 6.66, BLBD belongs to the top of the industry, outperforming 86.26% of the companies in the same industry.
  • The Debt to FCF ratio of BLBD is 0.55, which is an excellent value as it means it would take BLBD, only 0.55 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 0.55, BLBD belongs to the best of the industry, outperforming 91.60% of the companies in the same industry.
  • A Debt/Equity ratio of 0.31 indicates that BLBD is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.31, BLBD is in the better half of the industry, outperforming 62.60% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 0.55
Altman-Z 6.66
ROIC/WACC3.25
WACC9.61%
BLBD Yearly LT Debt VS Equity VS FCFBLBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

  • A Current Ratio of 1.81 indicates that BLBD should not have too much problems paying its short term obligations.
  • The Current ratio of BLBD (1.81) is worse than 61.07% of its industry peers.
  • A Quick Ratio of 1.21 indicates that BLBD should not have too much problems paying its short term obligations.
  • BLBD has a Quick ratio (1.21) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.21
BLBD Yearly Current Assets VS Current LiabilitesBLBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 28.08% over the past year.
  • Measured over the past years, BLBD shows a very strong growth in Earnings Per Share. The EPS has been growing by 39.87% on average per year.
  • BLBD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.61%.
  • Measured over the past years, BLBD shows a quite strong growth in Revenue. The Revenue has been growing by 10.98% on average per year.
EPS 1Y (TTM)28.08%
EPS 3YN/A
EPS 5Y39.87%
EPS Q2Q%8.7%
Revenue 1Y (TTM)11.61%
Revenue growth 3Y22.73%
Revenue growth 5Y10.98%
Sales Q2Q%6.12%

3.2 Future

  • Based on estimates for the next years, BLBD will show a small growth in Earnings Per Share. The EPS will grow by 4.42% on average per year.
  • Based on estimates for the next years, BLBD will show a small growth in Revenue. The Revenue will grow by 5.93% on average per year.
EPS Next Y0.46%
EPS Next 2Y6.43%
EPS Next 3Y4.42%
EPS Next 5YN/A
Revenue Next Year4.79%
Revenue Next 2Y4.1%
Revenue Next 3Y3.83%
Revenue Next 5Y5.93%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BLBD Yearly Revenue VS EstimatesBLBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
BLBD Yearly EPS VS EstimatesBLBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 12.52, the valuation of BLBD can be described as correct.
  • Based on the Price/Earnings ratio, BLBD is valued cheaply inside the industry as 93.13% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of BLBD to the average of the S&P500 Index (27.67), we can say BLBD is valued rather cheaply.
  • A Price/Forward Earnings ratio of 11.25 indicates a reasonable valuation of BLBD.
  • Based on the Price/Forward Earnings ratio, BLBD is valued cheaply inside the industry as 96.95% of the companies are valued more expensively.
  • BLBD is valuated cheaply when we compare the Price/Forward Earnings ratio to 27.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.52
Fwd PE 11.25
BLBD Price Earnings VS Forward Price EarningsBLBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 91.60% of the companies in the same industry are more expensive than BLBD, based on the Enterprise Value to EBITDA ratio.
  • BLBD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BLBD is cheaper than 93.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.87
EV/EBITDA 8.61
BLBD Per share dataBLBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BLBD does not grow enough to justify the current Price/Earnings ratio.
  • BLBD has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)27.38
PEG (5Y)0.31
EPS Next 2Y6.43%
EPS Next 3Y4.42%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • BLBD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BLUE BIRD CORP

NASDAQ:BLBD (2/12/2026, 8:00:02 PM)

After market: 55.96 0 (0%)

55.96

-1.81 (-3.13%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-04
Earnings (Next)05-05
Inst Owners113.59%
Inst Owner Change-1.05%
Ins Owners0.81%
Ins Owner Change2.92%
Market Cap1.77B
Revenue(TTM)1.50B
Net Income(TTM)129.75M
Analysts82.86
Price Target65.03 (16.21%)
Short Float %16.97%
Short Ratio12.08
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.62%
Min EPS beat(2)20.09%
Max EPS beat(2)25.16%
EPS beat(4)3
Avg EPS beat(4)16.38%
Min EPS beat(4)-0.8%
Max EPS beat(4)25.16%
EPS beat(8)7
Avg EPS beat(8)30.67%
EPS beat(12)11
Avg EPS beat(12)59.19%
EPS beat(16)12
Avg EPS beat(16)-79.92%
Revenue beat(2)2
Avg Revenue beat(2)2.88%
Min Revenue beat(2)0.25%
Max Revenue beat(2)5.51%
Revenue beat(4)3
Avg Revenue beat(4)2.03%
Min Revenue beat(4)-0.95%
Max Revenue beat(4)5.51%
Revenue beat(8)5
Avg Revenue beat(8)3.11%
Revenue beat(12)9
Avg Revenue beat(12)4.96%
Revenue beat(16)12
Avg Revenue beat(16)7.06%
PT rev (1m)0%
PT rev (3m)7.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.95%
EPS NY rev (1m)0%
EPS NY rev (3m)1.03%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.52%
Valuation
Industry RankSector Rank
PE 12.52
Fwd PE 11.25
P/S 1.18
P/FCF 10.87
P/OCF 9.48
P/B 6.51
P/tB 8.37
EV/EBITDA 8.61
EPS(TTM)4.47
EY7.99%
EPS(NY)4.97
Fwd EY8.89%
FCF(TTM)5.15
FCFY9.2%
OCF(TTM)5.9
OCFY10.54%
SpS47.46
BVpS8.59
TBVpS6.69
PEG (NY)27.38
PEG (5Y)0.31
Graham Number29.39
Profitability
Industry RankSector Rank
ROA 20.2%
ROE 47.81%
ROCE 42.19%
ROIC 31.2%
ROICexc 76.78%
ROICexgc 120.5%
OM 11.46%
PM (TTM) 8.65%
GM 20.97%
FCFM 10.85%
ROA(3y)15.41%
ROA(5y)6.73%
ROE(3y)58.56%
ROE(5y)N/A
ROIC(3y)29.27%
ROIC(5y)N/A
ROICexc(3y)58.87%
ROICexc(5y)N/A
ROICexgc(3y)104.89%
ROICexgc(5y)N/A
ROCE(3y)39.57%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y47.59%
ROICexc growth 3YN/A
ROICexc growth 5Y50.42%
OM growth 3YN/A
OM growth 5Y35.18%
PM growth 3YN/A
PM growth 5Y44.13%
GM growth 3Y65.07%
GM growth 5Y13.39%
F-Score7
Asset Turnover2.33
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 0.55
Debt/EBITDA 0.45
Cap/Depr 151.15%
Cap/Sales 1.58%
Interest Coverage 26.47
Cash Conversion 99.4%
Profit Quality 125.35%
Current Ratio 1.81
Quick Ratio 1.21
Altman-Z 6.66
F-Score7
WACC9.61%
ROIC/WACC3.25
Cap/Depr(3y)101.02%
Cap/Depr(5y)87.95%
Cap/Sales(3y)1.14%
Cap/Sales(5y)1.2%
Profit Quality(3y)226.25%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.08%
EPS 3YN/A
EPS 5Y39.87%
EPS Q2Q%8.7%
EPS Next Y0.46%
EPS Next 2Y6.43%
EPS Next 3Y4.42%
EPS Next 5YN/A
Revenue 1Y (TTM)11.61%
Revenue growth 3Y22.73%
Revenue growth 5Y10.98%
Sales Q2Q%6.12%
Revenue Next Year4.79%
Revenue Next 2Y4.1%
Revenue Next 3Y3.83%
Revenue Next 5Y5.93%
EBIT growth 1Y27.81%
EBIT growth 3YN/A
EBIT growth 5Y50.02%
EBIT Next Year30.97%
EBIT Next 3Y13.03%
EBIT Next 5YN/A
FCF growth 1Y80.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y85.98%
OCF growth 3YN/A
OCF growth 5Y119.48%

BLUE BIRD CORP / BLBD FAQ

Can you provide the ChartMill fundamental rating for BLUE BIRD CORP?

ChartMill assigns a fundamental rating of 6 / 10 to BLBD.


What is the valuation status for BLBD stock?

ChartMill assigns a valuation rating of 7 / 10 to BLUE BIRD CORP (BLBD). This can be considered as Undervalued.


Can you provide the profitability details for BLUE BIRD CORP?

BLUE BIRD CORP (BLBD) has a profitability rating of 7 / 10.


What are the PE and PB ratios of BLUE BIRD CORP (BLBD) stock?

The Price/Earnings (PE) ratio for BLUE BIRD CORP (BLBD) is 12.52 and the Price/Book (PB) ratio is 6.51.


Can you provide the expected EPS growth for BLBD stock?

The Earnings per Share (EPS) of BLUE BIRD CORP (BLBD) is expected to grow by 0.46% in the next year.